Clinical Trial Update: Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of Mesenchymal precursor cells for diabetic nephropathy has completed. The sponsor is Mesoblast Lt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Mesenchymal precursor cells (mesenchymal precursor cells)

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Diabetic Nephropathy, Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED